Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00985140 · ClinicalTrials.gov registry record
Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 13
- Enrollment target
NCT00985140: Clinical Trial study, sponsored by Stanford University.
NCT00985140 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00985140 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
To examine the efficacy and safety of total skin electron beam therapy to a dose of 12 Gray (TSEBT 12 Gy) in patients who have mycosis fungoides (MF) staged as IB to IIIA.
Primary Outcome
After the completion of TSEBT, patients will be followed every 4 weeks until 24 weeks ,and then every 8 weeks for a total of 12 months or until there is disease progression, relapse, or the initiation of a new anti-cancer therapy. The primary endpoint for the trial was the clinical response rate as defined by the modified severity weighted assessment tool (mSWAT) Partial response was defined as 50% improvement in the mSWAT. Complete response was complete disappearance of disease.
Interventions
- RADIATION Total Skin Electron Beam Therapy (TSEBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-05 |
Why NCT00985140 stopped before completion
NCT00985140 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Total Skin Electron Beam Therapy (TSEBT) is the first listed.
NCT00985140 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00985140 about?
NCT00985140 is a clinical study titled "Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides". To examine the efficacy and safety of total skin electron beam therapy to a dose of 12 Gray (TSEBT 12 Gy) in patients who have mycosis fungoides (MF) staged as IB to IIIA.
What is the current status of trial NCT00985140?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2009-06. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00985140?
The interventions under investigation include: Total Skin Electron Beam Therapy (TSEBT) (RADIATION).
Who is sponsoring clinical trial NCT00985140?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia